BioCentury
DATA GRAPHICS | Data Byte

Italian seed and series A financings since 2020

At least 12 Italian start-ups have attracted seed or series A funding since 2020, with Sofinnova and Claris the most active VCs

May 9, 2022 6:33 PM UTC

At least 12 Italian biotech start-ups have raised a seed or series A round since the start of 2020, reflecting the region’s growing capacity to support biotech company creation.

European VC firm Sofinnova Partners has been a powerhouse in the region, leading or co-leading nine of the 12 financings, mostly by way of its Sofinnova Telethon Fund. The vehicle launched two years ago in a partnership with Italian charity Fondazione Telethon with €108 million ($117.4 million) to invest in rare genetic disease start-ups in Italy.  ...

Get Unlimited Access
Continue reading with a free trial.
Or Purchase This Article